Trial intelligence / Profile preview

Lazanda in Cancer Patients Receiving Palliative Radiation

NCT03071744Phase 2Terminated

Start
Mar 2017
Primary completion
Mar 2018
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of fentanyl in bone metastases, cancer pain. Started Mar 2017; status: terminated.

02

Drugs

fentanyl
03

Conditions

bone metastasescancer pain

Beyond the preview

Go deeper on NCT03071744.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03071744.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call